A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Makanga, Michael ^a  

^a European & Developing Countries Clinical Trials Partnership   (Netherlands)

Author keywords

Artemether lumefantrine; Gametocytes; Malaria eradication; Systematic review

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; DIHYDROARTEMISININ PLUS PIPERAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

DEMOGRAPHY; DISEASE CLEARANCE; DISEASE TRANSMISSION; DRUG EFFECT; DRUG RESISTANCE; GAMETOCYTE; HUMAN; LIFE CYCLE; MALARIA; MALARIA CONTROL; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); PLASMODIUM; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; CYTOLOGY; DRUG COMBINATION; DRUG EFFECTS; GENETICS; MALARIA FALCIPARUM; PARASITOLOGY; PLASMODIUM FALCIPARUM; TROPHOZOITE;

ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; ETHANOLAMINES; FLUORENES; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; TROPHOZOITES;

EID: 84904783240     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-291     Document Type: Review

References (91)

1. World Health Organization, World Malaria Report 2013 [ http://www.who.int/malaria/publications/world-malaria-report-2013/report/en/index.html ]
2. The challenge to avoid anti-malarial medicine stock-outs in an era of funding partners: the case of Tanzania. Mikkelsen-Lopez I, Shango W, Barrington J, Ziegler R, Smith T, de Savigny D, Malar J 2014 13 181
3. Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up. Shretta R, Yadav P, Malar J 2012 11 399
4. World Health Organization, Progress in the Development of the Global Strategic Plan for Plasmodium vivax Control and Elimination [ http://www.who.int/malaria/mpac/mpac-sep13-global-p-vivax-strategy-update.pdf]
5. The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. Okell LC, Griffin JT, Kleinschmidt I, Hollingsworth TD, Churcher TS, White MJ, Bousema T, Drakeley CJ, Ghani AC, PLoS One 2011 6 20179
6. The role of antimalarial treatment in the elimination of malaria. Gosling RD, Okell L, Mosha J, Chandramohan D, Clin Microbiol Infect 2011 17 1617 1623
7. Transitioning from malaria control to elimination: the vital role of ACTs. Grueninger H, Hamed K, Trends Parasitol 2013 29 60 64
8. The future of artemisinins: natural, synthetic or recombinant? Hommel M, J Biol 2008 7 38
9. The role of anti-malarial drugs in eliminating malaria. White NJ, Malar J 2008 7 Suppl 1 8
10. Antimalarial drug resistance. White NJ, J Clin Invest 2004 113 1084 1092
11. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Bousema T, Drakeley C, Clin Microbiol Rev 2011 24 377 410
12. The effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children. Kakuru A, Jagannathan P, Arinaitwe E, Wanzira H, Muhindo M, Bigira V, Osilo E, Homsy J, Kamya MR, Tappero JW, Dorsey G, Am J Trop Med Hyg 2013 88 736 743
13. Gametocyte carriage in Plasmodium falciparum-infected travellers. Roberts CH, Armstrong M, Zatyka E, Boadi S, Warren S, Chiodini PL, Sutherland CJ, Doherty T, Malar J 2013 12 31
14. Plasmodium falciparum gametocyte carriage, emergence, clearance and population sex ratios in anaemic and non-anaemic malarious children. Gbotosho GO, Sowunmi A, Okuboyejo TM, Happi CT, Michael OS, Folarin OA, Adewoye EO, Mem Inst Oswaldo Cruz 2011 106 562 569
15. Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children before and after artemisinin-based combination treatments. Sowunmi A, Okuboyejo TM, Gbotosho GO, Happi CT, Chemotherapy 2011 57 497 504
16. World Health Organization, Guidelines for the treatment of malaria Geneva: WHO Press 2 2010 http://www.who.int/malaria/publications/atoz/9789241547925/en/
17. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, Sutherland C, Sauerwein R, Ghani AC, Drakeley C, Malar J 2010 9 136
18. Population biology and antimalarial resistance: the transmission of antimalarial drug resistance in Plasmodium falciparum. Barnes KI, White NJ, Acta Trop 2005 94 230 240
19. Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ, Malar J 2008 7 125
20. Development of antimalarial drugs and their application in China: a historical review. Chen C, Infect Dis Poverty 2014 3 9
21. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. Eziefula AC, Bousema T, Yeung S, Kamya M, Owaraganise A, Gabagaya G, Bradley J, Grignard L, Lanke KH, Wanzira H, Mpimbaza A, Nsobya S, White NJ, Webb EL, Staedke SG, Drakeley C, Lancet Infect Dis 2014 14 130 139
22. Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. Beshir KB, Sutherland CJ, Sawa P, Drakeley CJ, Okell L, Mweresa CK, Omar SA, Shekalaghe SA, Kaur H, Ndaro A, Chilongola J, Schallig HD, Sauerwein RW, Hallett RL, Bousema T, J Infect Dis 2013 208 2017 2024
23. Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region. Joseph D, Kabanywanyi AM, Hulser R, Premji Z, Minzi OM, Mugittu K, Tanzania Malar J 2013 12 60
24. A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso. Tiono AB, Ouédraogo A, Ogutu B, Diarra A, Coulibaly S, Gansané A, Sirima SB, O'Neil G, Mukhopadhyay A, Hamed K, Malar J 2013 12 79
25. Comparative evaluation of efficacy and safety of artesunate-lumefantrine vs. artemether-lumefantrine fixed-dose combination in the treatment of uncomplicated Plasmodium falciparum malaria. Pareek A, Chandurkar N, Srivastav V, Lakhani J, Karmakar PS, Basu S, Ray A, Pednekar S, Gupta PB, Suthar N, Lakhani S, Trop Med Int Health 2013 18 578 587
26. Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial. Sawa P, Shekalaghe SA, Drakeley CJ, Sutherland CJ, Mweresa CK, Baidjoe AY, Manjurano A, Kavishe RA, Beshir KB, Yussuf RU, Omar SA, Hermsen CC, Okell L, Schallig HD, Sauerwein RW, Hallett RL, Bousema T, J Infect Dis 2013 207 1637 1645
27. Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana. Abuaku B, Duah N, Quaye L, Quashie N, Koram K, Malar J 2012 11 388
28. Plasmodium falciparum gametocyte carriage, sex ratios and asexual parasite rates in Nigerian children before and after a treatment protocol policy change instituting the use of artemisinin-based combination therapies. Gbotosho GO, Sowunmi A, Happi CT, Okuboyejo TM, Mem Inst Oswaldo Cruz 2011 106 685 690
29. Kinetics of Plasmodium falciparum gametocyte sex ratios: application to the evaluation of the potential of antimalarial drugs to influence malaria transmission. Gbotosho GO, Sowunmi A, Happi CT, Open Trop Med J 2011 4 33 38
30. Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis. Makanga M, Bassat Q, Falade CO, Premji ZG, Krudsood S, Hunt P, Walter V, Beck HP, Marrast AC, Cousin M, Rosenthal PJ, Am J Trop Med Hyg 2011 85 793 804
31. A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. The Four Artemisinin-Based Combinations (4ABC) Study Group, PLoS Med 2011 8 1001119
32. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo AP, Naing AL, Nyo MY, Myint NZ, Imwong M, Ashley E, Lee SJ, White NJ, Lancet Infect Dis 2010 10 673 681
33. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SS, Bustos DG, Tjitra E, Bedu-Addo G, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, Pyronaridine-artesunate Study Team, Lancet 2010 375 1457 1467
34. A method of active case detection to target reservoirs of asymptomatic malaria and gametocyte carriers in a rural area in Southern Province. Stresman GH, Kamanga A, Moono P, Hamapumbu H, Mharakurwa S, Kobayashi T, Moss WJ, Shiff C, Zambia Malar J 2010 9 265
35. Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance. Okafor HU, Shu EN, Oguonu T, J Trop Pediatr 2010 56 398 406
36. Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast. Faye B, Offianan AT, Ndiaye JL, Tine RC, Touré W, Djoman K, Sylla K, Ndiaye PS, Penali L, Gaye O, Trop Med Int Health 2010 15 608 613
37. ®) against Plasmodium falciparum in Kersa. South West Ethiopia. Assefa A, Kassa M, Tadese G, Mohamed H, Animut A, Mengesha T, Parasit Vectors 2010 3 1
38. Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children. Sowunmi A, Adewoye EO, Gbotsho GO, Happi CT, Sijuade A, Folarin OA, Okuboyejo TM, Michael OS, Malar J 2010 9 53
39. Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. Achan J, Tibenderana JK, Kyabayinze D, Wabwire Mangen F, Kamya MR, Dorsey G, D'Alessandro U, Rosenthal PJ, Talisuna AO, Br Med J 2009 339 2763
40. Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, Cohuet S, D'Alessandro U, Djimdé A, Karema C, Guthmann JP, Hamour S, Ndiaye JL, Mårtensson A, Rwagacondo C, Sagara I, Same-Ekobo A, Sirima SB, van den Broek I, Yeka A, Taylor WR, Dorsey G, Randrianarivelojosia M, Malar J 2009 8 203
41. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. Happi CT, Gbotosho GO, Folarin OA, Sowunmi A, Hudson T, O'Neil M, Milhous W, Wirth DF, Oduola AM, Antimicrob Agents Chemother 2009 53 888 895
42. Plasmodium falciparum gametocyte sex ratios in symptomatic children treated with antimalarial drugs. Sowunmi A, Balogun ST, Gbotosho GO, Happi CT, Acta Trop 2009 109 108 117
43. Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. Bassat Q, Mulenga M, Tinto H, Piola P, Borrmann S, Menéndez C, Nambozi M, Valéa I, Nabasumba C, Sasi P, Bacchieri A, Corsi M, Ubben D, Talisuna A, D'Alessandro U, PLoS One 2009 4 7871
44. Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis. Zwang J, Ashley EA, Karema C, D'Alessandro U, Smithuis F, Dorsey G, Janssens B, Mayxay M, Newton P, Singhasivanon P, Stepniewska K, White NJ, Nosten F, PLoS One 2009 4 6358
45. Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria. Premji Z, Umeh RE, Owusu-Agyei S, Esamai F, Ezedinachi EU, Oguche S, Borrmann S, Sowunmi A, Duparc S, Kirby PL, Pamba A, Kellam L, Guiguemdé R, Greenwood B, Ward SA, Winstanley PA, PLoS One 2009 4 6682
46. Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya. Oesterholt MJ, Alifrangis M, Sutherland CJ, Omar SA, Sawa P, Howitt C, Gouagna LC, Sauerwein RW, Bousema T, PLoS One 2009 4 4364
47. Possible interruption of malaria transmission, highland Kenya, 2007-2008. John CC, Riedesel MA, Magak NG, Lindblade KA, Menge DM, Hodges JS, Vulule JM, Akhwale W, Emerg Infect Dis 2009 15 1917 1924
48. Population structure of Plasmodium falciparum gametocyte sex ratios in malarious children in an endemic area. Sowunmi A, Gbotosho GO, Happi CT, Folarin OA, Balogun ST, Parasitol Int 2009 58 438 443
49. The clinical efficacy of artemether/lumefantrine (Coartem). Makanga M, Krudsood S, Malar J 2009 8 Suppl 1 5
50. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. Yeka A, Dorsey G, Kamya MR, Talisuna A, Lugemwa M, Rwakimari JB, Staedke SG, Rosenthal PJ, Wabwire-Mangen F, Bukirwa H, PLoS One 2008 3 2390
51. Activities of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine against sexual-stage parasites in falciparum malaria in children. Sowunmi A, Balogun T, Gbotosho GO, Happi CT, Adedeji AA, Bolaji OM, Fehintola FA, Folarin OA, Chemotherapy 2008 54 201 208
52. A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya. Mens PF, Sawa P, van Amsterdam SM, Versteeg I, Omar SA, Schallig HD, Kager PA, Malar J 2008 7 237
53. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya. Juma EA, Obonyo CO, Akhwale WS, Ogutu BR, Malar J 2008 7 262
54. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study. Hatz C, Soto J, Nothdurft HD, Zoller T, Weitzel T, Loutan L, Bricaire F, Gay F, Burchard GD, Andriano K, Lefèvre G, De Palacios PI, Genton B, Am J Trop Med Hyg 2008 78 241 247
55. Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in Southwestern Nigeria. Sowunmi A, Gbotosho GO, Happi CT, Adedeji AA, Fehintola FA, Folarin OA, Tambo E, Fateye BA, Am J Trop Med Hyg 2007 77 235 241
56. Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan. Ibrahium AM, Kheir MM, Osman ME, Khalil IF, Alifrangis M, Elmardi KA, Malik EM, Adam I, Ann Trop Med Parasitol 2007 101 15 21
57. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. Kamya MR, Yeka A, Bukirwa H, Lugemwa M, Rwakimari JB, Staedke SG, Talisuna AO, Greenhouse B, Nosten F, Rosenthal PJ, Wabwire-Mangen F, Dorsey G, PLoS Clin Trials 2007 2 20
58. Comparison of artemether-lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in eastern Nepal. Thapa S, Hollander J, Linehan M, Cox-Singh J, Bista MB, Thakur GD, Davis WA, Davis TM, Am J Trop Med Hyg 2007 77 423 430
59. Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Schneider P, Bousema JT, Gouagna LC, Otieno S, van de Vegte-Bolmer M, Omar SA, Sauerwein RW, Am J Trop Med Hyg 2007 76 470 474
60. High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola. Guthmann JP, Cohuet S, Rigutto C, Fortes F, Saraiva N, Kiguli J, Kyomuhendo J, Francis M, Noël F, Mulemba M, Balkan S, Am J Trop Med Hyg 2006 75 143 145
61. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. Bousema JT, Schneider P, Gouagna LC, Drakeley CJ, Tostmann A, Houben R, Githure JI, Ord R, Sutherland CJ, Omar SA, Sauerwein RW, J Infect Dis 2006 193 1151 1159
62. Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia. Chanda P, Hawela M, Kango M, Sipilanyambe N, Malar J 2006 5 75
63. Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo. van den Broek I, Kitz C, Al Attas S, Libama F, Balasegaram M, Guthmann JP, Malar J 2006 5 113
64. Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data. Makanga M, Premji Z, Falade C, Karbwang J, Mueller EA, Andriano K, Hunt P, De Palacios PI, Am J Trop Med Hyg 2006 74 991 998
65. Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine + artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Mutabingwa TK, Anthony D, Heller A, Hallett R, Ahmed J, Drakeley C, Greenwood BM, Whitty CJ, Lancet 2005 365 1474 1480
66. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, Alexander N, Coleman R, Pinder M, Walraven G, Targett GA, PLoS Med 2005 2 92
67. Efficacy of chloroquine + sulfadoxine-pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh. van den Broek IV, Maung UA, Peters A, Liem L, Kamal M, Rahman M, Rahman MR, Bangali AM, Das S, Barends M, Faiz AM, Trans R Soc Trop Med Hyg 2005 99 727 735
68. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL, South Africa PLoS Med 2005 2 330
69. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. Koram KA, Abuaku B, Duah N, Quashie N, Acta Trop 2005 95 194 203
70. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. Lefèvre G, Looareesuwan S, Treeprasertsuk S, Krudsood S, Silachamroon U, Gathmann I, Mull R, Bakshi R, Am J Trop Med Hyg 2001 64 247 256
71. A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand. Looareesuwan S, Wilairatana P, Chokejindachai W, Chalermrut K, Wernsdorfer W, Gemperli B, Gathmann I, Royce C, Am J Trol Med Hyg 1999 60 238 243
72. A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. von Seidlein L, Bojang K, Jones P, Jaffar S, Pinder M, Obaro S, Doherty T, Haywood M, Snounou G, Gemperli B, Gathmann I, Royce C, McAdam K, Greenwood B, Am J Trop Med Hyg 1998 58 638 644
73. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. Vugt MV, Wilairatana P, Gemperli B, Gathmann I, Phaipun L, Brockman A, Luxemburger C, White NJ, Nosten F, Looareesuwan S, Am J Trop Med Hyg 1999 60 936 942
74. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. van Vugt M, Looareesuwan S, Wilairatana P, McGready R, Villegas L, Gathmann I, Mull R, Brockman A, White NJ, Nosten F, Trans R Soc Trop Med Hyg 2000 94 545 548
75. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. Abdulla S, Sagara I, Borrmann S, D'Alessandro U, González R, Hamel M, Ogutu B, Mårtensson A, Lyimo J, Maiga H, Sasi P, Nahum A, Bassat Q, Juma E, Otieno L, Björkman A, Beck HP, Andriano K, Cousin M, Lefèvre G, Ubben D, Premji Z, Lancet 2008 372 1819 1827
76. Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. Falade C, Makanga M, Premji Z, Ortmann CE, Stockmeyer M, de Palacios PI, Trans R Soc Trop Med Hyg 2005 99 459 467
77. Data on file, Study COA2412. Novartis, 2005
78. Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis. Kern SE, Tiono AB, Makanga M, Gbadoé AD, Premji Z, Gaye O, Sagara I, Ubben D, Cousin M, Oladiran F, Sander O, Ogutu B, Malar J 2011 10 210
79. Sub-microscopic gametocyte carriage in febrile children living in different areas of Gabon. Mawili-Mboumba DP, Nikiéma R, Bouyou-Akotet MK, Bahamontes-Rosa N, Traoré A, Kombila M, Malar J 2013 12 375
80. Population at increased risk for HIV infection in Kenya: results from a national population-based household survey, 2012. Githuka G, Hladik W, Mwalili S, Cherutich P, Muthui M, Gitonga J, Maina WK, Kim AA, on behalf of the KAIS Study Group, J Acquir Immune Defic Syndr 2014 66 Suppl. 1 46 S56
81. A reversal in reductions of child mortality in western Kenya, 2003-2009. Hamel MJ, Adazu K, Obor D, Sewe M, Vulule J, Williamson JM, Slutsker L, Feikin DR, Laserson KF, Am J Trop Med Hyg 2011 85 597 605
82. Partnering parasites: evidence of synergism between heavy Schistosoma haemotobium and Plasmodium species infections in Kenyan children. Florey LS, King CH, Van Dyke MK, Muchiri EM, Mungai PL, Zimmerman PA, Wilson ML, PLoS Negl Trop Dis 2012 6 1723
83. Changing malaria intervention coverage, transmission and hospitalization in Kenya. Okiro EA, Alegana VA, Noor AM, Snow RW, Malar J 2010 9 285
84. UNICEF, At a Glance: Gambia [ http://www.unicef.org/infobycountry/gambia-statistics.html ]
85. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJ, Sesay SS, Abubakar I, Dunyo S, Sey O, Palmer A, Fofana M, Corrah T, Bojang KA, Whittle HC, Greenwood BM, Conway DJ, Lancet 2008 372 1545 1554
86. Continued decline of malaria in The Gambia with implications for elimination. Ceesay SJ, Casals-Pascual C, Nwakanma DC, Walther M, Gomez-Escobar N, Fulford AJ, Takem EN, Nogaro S, Bojang KA, Corrah T, Jaye MC, Taal MA, Sonko AA, Conway DJ, PLoS One 2010 5 12242
87. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Maude RJ, Pontavornpinyo W, Saralamba S, Aguas R, Yeung S, Dondorp AM, Day NP, White NJ, White LJ, Malar J 2009 8 31
88. Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance. Maude RJ, Socheat D, Nguon C, Saroth P, Dara P, Li G, Song J, Yeung S, Dondorp AM, Day NP, White NJ, White LJ, PLoS One 2012 7 37166
89. Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence. Banek K, Lalani M, Staedke SG, Chandramohan D, Malar J 2014 13 7
90. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria. Zani B, Gathu M, Donegan S, Olliaro PL, Sinclair D, Cochrane Database Syst Rev 2014 1 D010927
91. Low-dose primaquine for falciparum malaria. Meltzer E, Schwartz E, Lancet Infect Dis 2014 14 449